{"id":446315,"date":"2021-02-26T16:33:11","date_gmt":"2021-02-26T21:33:11","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=446315"},"modified":"2021-02-26T16:33:11","modified_gmt":"2021-02-26T21:33:11","slug":"glycomimetics-to-present-at-three-upcoming-virtual-healthcare-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/glycomimetics-to-present-at-three-upcoming-virtual-healthcare-investor-conferences\/","title":{"rendered":"GlycoMimetics to Present at Three Upcoming Virtual Healthcare Investor Conferences"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwmarginl1 { margin-left: 30px }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>GlycoMimetics to Present at Three Upcoming Virtual Healthcare Investor Conferences<\/b><\/p>\n<p>ROCKVILLE, Md.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nGlycoMimetics, Inc. (Nasdaq: GLYC), today announces that executives from the Company plan to participate in three virtual healthcare conferences in March. More information about the presentations and panel discussions will be available on the Company\u2019s website, under the Investors tab. Details are as follows:\n<\/p>\n<p class=\"bwmarginl1\"><b>Cowen 41st Annual Health Care Conference<br \/>\n<br \/><\/b>March 1 \u2013 March 4, 2021<br \/>\n<br \/>Eric Feldman, M.D., GlycoMimetics Vice President, Clinical Development, to participate in Leukemias Panel<br \/>\n<br \/>Wed, March 3, 2021, 11:40 a.m. \u2013 12:40 p.m. (EST)<br \/>\n<br \/>Access to the panel discussion is for registered attendees only.\n<\/p>\n<p class=\"bwmarginl1\"><b>H.C. Wainwright Global Life Sciences Conference<br \/>\n<br \/><\/b>March 9 \u2013 10, 2021<br \/>\n<br \/>Rachel King, GlycoMimetics CEO, to present a corporate overview<br \/>\n<br \/>The presentation will be available on-demand, beginning at 7 a.m. ET, March 9 through March 10. Access will be provided through the Company\u2019s website (Investors section) and archived for 90 days.\n<\/p>\n<p class=\"bwmarginl1\"><b>33rd Annual Virtual Roth Conference<br \/>\n<br \/><\/b>March 15 \u2013 17, 2021<br \/>\n<br \/>Rachel King, GlycoMimetics CEO, to present a corporate overview<br \/>\n<br \/>Mon, March 15, 10:00 a.m. \u2013 12:00 p.m. (EST) in Virtual 2 (Panel: Navigating Clinical Development in Rare Hematology &amp; Inflammatory Disease). A link to the panel session will be available in the Investors section of the GlycoMimetics website.\n<\/p>\n<p><b>About GlycoMimetics, Inc.<\/b><\/p>\n<p>\nGlycoMimetics is a biotechnology company with a focus in hematology-oncology and a pipeline of novel glycomimetic drugs, all designed to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. GlycoMimetics\u2019 drug candidate, uproleselan, an E-selectin antagonist, was evaluated in a Phase 1\/2 clinical trial as a potential treatment for AML and is being evaluated across a range of patient populations including in a Company-sponsored Phase 3 trial in relapsed\/refractory AML under Breakthrough Therapy Designation. Rivipansel, a pan-selectin antagonist, is being explored for use in treatment of acute VOC in sickle cell disease. GlycoMimetics has also completed a Phase 1 clinical trial with another wholly-owned drug candidate, GMI-1359, a combined CXCR4 and E-selectin antagonist. GlycoMimetics is located in Rockville, MD in the BioHealth Capital Region. Learn more at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.glycomimetics.com&amp;esheet=52386766&amp;newsitemid=20210226005644&amp;lan=en-US&amp;anchor=www.glycomimetics.com&amp;index=1&amp;md5=4688d5085ce67cc3e0494370b1058d2e\">www.glycomimetics.com<\/a>.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210226005644r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20210226005644\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20210226005644\/en\/<\/a><\/span><\/p>\n<p>\nInvestor:<br \/>\n<br \/>Shari Annes<br \/>\n<br \/>Phone: 650-888-0902<br \/>\n<br \/>Email: <a rel=\"nofollow\" href=\"mailto:sannes@annesassociates.com\">sannes@annesassociates.com<\/a><\/p>\n<p>\nMedia:<br \/>\n<br \/>Jamie Lacey-Moreira<br \/>\n<br \/>Phone: 410-299-3310<br \/>\n<br \/>Email: <a rel=\"nofollow\" href=\"mailto:jamielacey@presscommpr.com\">jamielacey@presscommpr.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> Maryland United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Health FDA Clinical Trials Research Science Pharmaceutical Biotechnology<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20210226005644\/en\/26247\/3\/GlycoMimetics.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>GlycoMimetics to Present at Three Upcoming Virtual Healthcare Investor Conferences ROCKVILLE, Md.&#8211;(BUSINESS WIRE)&#8211; GlycoMimetics, Inc. (Nasdaq: GLYC), today announces that executives from the Company plan to participate in three virtual healthcare conferences in March. More information about the presentations and panel discussions will be available on the Company\u2019s website, under the Investors tab. Details are as follows: Cowen 41st Annual Health Care Conference March 1 \u2013 March 4, 2021 Eric Feldman, M.D., GlycoMimetics Vice President, Clinical Development, to participate in Leukemias Panel Wed, March 3, 2021, 11:40 a.m. \u2013 12:40 p.m. (EST) Access to the panel discussion is for registered attendees only. H.C. Wainwright Global Life Sciences Conference March 9 \u2013 10, 2021 Rachel King, GlycoMimetics CEO, to present a &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/glycomimetics-to-present-at-three-upcoming-virtual-healthcare-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;GlycoMimetics to Present at Three Upcoming Virtual Healthcare Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-446315","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>GlycoMimetics to Present at Three Upcoming Virtual Healthcare Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/glycomimetics-to-present-at-three-upcoming-virtual-healthcare-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GlycoMimetics to Present at Three Upcoming Virtual Healthcare Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"GlycoMimetics to Present at Three Upcoming Virtual Healthcare Investor Conferences ROCKVILLE, Md.&#8211;(BUSINESS WIRE)&#8211; GlycoMimetics, Inc. (Nasdaq: GLYC), today announces that executives from the Company plan to participate in three virtual healthcare conferences in March. More information about the presentations and panel discussions will be available on the Company\u2019s website, under the Investors tab. Details are as follows: Cowen 41st Annual Health Care Conference March 1 \u2013 March 4, 2021 Eric Feldman, M.D., GlycoMimetics Vice President, Clinical Development, to participate in Leukemias Panel Wed, March 3, 2021, 11:40 a.m. \u2013 12:40 p.m. (EST) Access to the panel discussion is for registered attendees only. H.C. Wainwright Global Life Sciences Conference March 9 \u2013 10, 2021 Rachel King, GlycoMimetics CEO, to present a &hellip; Continue reading &quot;GlycoMimetics to Present at Three Upcoming Virtual Healthcare Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/glycomimetics-to-present-at-three-upcoming-virtual-healthcare-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-02-26T21:33:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210226005644r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/glycomimetics-to-present-at-three-upcoming-virtual-healthcare-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/glycomimetics-to-present-at-three-upcoming-virtual-healthcare-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"GlycoMimetics to Present at Three Upcoming Virtual Healthcare Investor Conferences\",\"datePublished\":\"2021-02-26T21:33:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/glycomimetics-to-present-at-three-upcoming-virtual-healthcare-investor-conferences\\\/\"},\"wordCount\":395,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/glycomimetics-to-present-at-three-upcoming-virtual-healthcare-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210226005644r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/glycomimetics-to-present-at-three-upcoming-virtual-healthcare-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/glycomimetics-to-present-at-three-upcoming-virtual-healthcare-investor-conferences\\\/\",\"name\":\"GlycoMimetics to Present at Three Upcoming Virtual Healthcare Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/glycomimetics-to-present-at-three-upcoming-virtual-healthcare-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/glycomimetics-to-present-at-three-upcoming-virtual-healthcare-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210226005644r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2021-02-26T21:33:11+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/glycomimetics-to-present-at-three-upcoming-virtual-healthcare-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/glycomimetics-to-present-at-three-upcoming-virtual-healthcare-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/glycomimetics-to-present-at-three-upcoming-virtual-healthcare-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210226005644r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210226005644r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/glycomimetics-to-present-at-three-upcoming-virtual-healthcare-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GlycoMimetics to Present at Three Upcoming Virtual Healthcare Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GlycoMimetics to Present at Three Upcoming Virtual Healthcare Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/glycomimetics-to-present-at-three-upcoming-virtual-healthcare-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"GlycoMimetics to Present at Three Upcoming Virtual Healthcare Investor Conferences - Market Newsdesk","og_description":"GlycoMimetics to Present at Three Upcoming Virtual Healthcare Investor Conferences ROCKVILLE, Md.&#8211;(BUSINESS WIRE)&#8211; GlycoMimetics, Inc. (Nasdaq: GLYC), today announces that executives from the Company plan to participate in three virtual healthcare conferences in March. More information about the presentations and panel discussions will be available on the Company\u2019s website, under the Investors tab. Details are as follows: Cowen 41st Annual Health Care Conference March 1 \u2013 March 4, 2021 Eric Feldman, M.D., GlycoMimetics Vice President, Clinical Development, to participate in Leukemias Panel Wed, March 3, 2021, 11:40 a.m. \u2013 12:40 p.m. (EST) Access to the panel discussion is for registered attendees only. H.C. Wainwright Global Life Sciences Conference March 9 \u2013 10, 2021 Rachel King, GlycoMimetics CEO, to present a &hellip; Continue reading \"GlycoMimetics to Present at Three Upcoming Virtual Healthcare Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/glycomimetics-to-present-at-three-upcoming-virtual-healthcare-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2021-02-26T21:33:11+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210226005644r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/glycomimetics-to-present-at-three-upcoming-virtual-healthcare-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/glycomimetics-to-present-at-three-upcoming-virtual-healthcare-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"GlycoMimetics to Present at Three Upcoming Virtual Healthcare Investor Conferences","datePublished":"2021-02-26T21:33:11+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/glycomimetics-to-present-at-three-upcoming-virtual-healthcare-investor-conferences\/"},"wordCount":395,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/glycomimetics-to-present-at-three-upcoming-virtual-healthcare-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210226005644r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/glycomimetics-to-present-at-three-upcoming-virtual-healthcare-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/glycomimetics-to-present-at-three-upcoming-virtual-healthcare-investor-conferences\/","name":"GlycoMimetics to Present at Three Upcoming Virtual Healthcare Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/glycomimetics-to-present-at-three-upcoming-virtual-healthcare-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/glycomimetics-to-present-at-three-upcoming-virtual-healthcare-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210226005644r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2021-02-26T21:33:11+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/glycomimetics-to-present-at-three-upcoming-virtual-healthcare-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/glycomimetics-to-present-at-three-upcoming-virtual-healthcare-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/glycomimetics-to-present-at-three-upcoming-virtual-healthcare-investor-conferences\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210226005644r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210226005644r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/glycomimetics-to-present-at-three-upcoming-virtual-healthcare-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"GlycoMimetics to Present at Three Upcoming Virtual Healthcare Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/446315","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=446315"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/446315\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=446315"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=446315"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=446315"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}